Jefferies downgrades IAC stock rating to hold on M&A outlook By Investing.com

IAC reported Q1 2026 EPS of -$0.94 versus -$0.29 expected and revenue of $422.9 million versus $520.31 million expected, a clear earnings and sales miss. Jefferies downgraded the stock to hold from buy, citing limited M&A optionality, the loss of MGM as a catalyst, and greater dependence on People Inc. despite ongoing buybacks and portfolio simplification. IAC has repurchased 2.9 million shares, bought 1 million MGM shares, and sold Care.com for $296 million, but near-term catalysts remain limited.

Analysis

IAC is moving from a classic “optionality through M&A” setup to a narrower sum-of-the-parts story, and that usually compresses the holding-company multiple before it improves it. The key second-order effect is that when a conglomerate stops being a buyer of assets, investors stop underwriting future reinvestment and instead force the stock to trade on the weakest near-term earnings stream; that makes the core People asset the swing factor for sentiment, while the MGM stake becomes a quasi-liquid asset with less strategic value than investors hoped.

The market is also likely underestimating the reflexivity of buybacks here. Repurchases help on per-share math, but they can become a signaling problem if operating results remain soft: investors read buybacks as a lack of better internal uses for capital, which can support the balance sheet yet fail to re-rate the stock. In the next 1-2 quarters, the setup is especially fragile because there is no obvious catalyst to offset any disappointment in the core business, so multiple compression can persist even if cash flow remains adequate.

The contrarian angle is that the selloff may over-penalize the “no M&A” message if management is deliberately de-risking the story and reducing discount-rate uncertainty. A cleaner structure can matter if the market begins valuing the People business independently and assigns a more transparent value to the MGM stake; that rerating path is months, not days, and likely requires either a stronger operating inflection or a monetization event. Until then, the main risk is that MGM beta and weak core execution combine to keep the stock trapped below intrinsic value despite capital returns.

AMD is directionally irrelevant to this setup; any cross-readthrough is simply that AI winners are still getting rewarded for execution, while IAC is being punished for strategic ambiguity. That divergence should widen if investors continue to prefer asset-light growth stories over holding-company simplification plays.

Key Decisions for Investors

• Short IAC on strength for a 2-6 week horizon; the stock likely trades as a de-rated holding company until a concrete catalyst emerges. Risk/reward favors fading rallies because upside requires either a deal or a core operating surprise, while downside can continue on multiple compression.
• Consider a pair trade: long a cleaner capital-return/asset-monetization name versus short IAC over the next 1-3 months. The thesis is that market attention will favor businesses with visible cash generation and fewer governance/structure discounts over a simplification story with no near-term catalyst.
• Sell out-of-the-money IAC calls into any post-downgrade bounce. Implied volatility should stay elevated around strategic uncertainty, but upside is capped by the absence of M&A optionality and the market’s current skepticism on the core business.
• If already long IAC, trim into rallies and re-enter only after a catalyst-rich window such as a meaningful asset sale, a clearer People margin inflection, or a monetization plan for the MGM stake. Without that, the stock is likely range-bound with negative drift.